赛托生物(300583.SZ)取得倍他米松原料药CEP证书

智通财经网02-13

智通财经APP讯，赛托生物(300583.SZ)发布公告，公司控股子公司山东斯瑞药业有限公司(以下简称“斯瑞药业”)近日收到欧洲药品质量管理局(以下简称“EDQM”)签发的原料药欧洲药典适用性证书(以下简称“CEP证书”)。涉及化学原料药名称：“BETAMETHASONE 倍他米松”。公司取得倍他米松原料药CEP证书，标志着公司该原料药可以在认可CEP 证书的国际市场进行销售，将为公司倍他米松...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2611132885?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-02-13 16:36","share_image_url":"https://static.laohu8.com/6ca2dcdccfa2217fb20a0351f4efe814","id":"2611132885","market":"us","top_or_hot":-1,"title":"赛托生物(300583.SZ)取得倍他米松原料药CEP证书","media":"智通财经网","content":"<div>\n<p>智通财经APP讯，赛托生物(300583.SZ)发布公告，公司控股子公司山东斯瑞药业有限公司(以下简称“斯瑞药业”)近日收到欧洲药品质量管理局(以下简称“EDQM”)签发的原料药欧洲药典适用性证书(以下简称“CEP证书”)。涉及化学原料药名称：“BETAMETHASONE 倍他米松”。公司取得倍他米松原料药CEP证书，标志着公司该原料药可以在认可CEP 证书的国际市场进行销售，将为公司倍他米松...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1405158.html\">网页链接</a>\n\n</div>\n","source":"highlight_zhitongcaijin","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>赛托生物(300583.SZ)取得倍他米松原料药CEP证书</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n赛托生物(300583.SZ)取得倍他米松原料药CEP证书\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-02-13 16:36 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1405158.html><strong>智通财经网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，赛托生物(300583.SZ)发布公告，公司控股子公司山东斯瑞药业有限公司(以下简称“斯瑞药业”)近日收到欧洲药品质量管理局(以下简称“EDQM”)签发的原料药欧洲药典适用性证书(以下简称“CEP证书”)。涉及化学原料药名称：“BETAMETHASONE 倍他米松”。公司取得倍他米松原料药CEP证书，标志着公司该原料药可以在认可CEP 证书的国际市场进行销售，将为公司倍他米松...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1405158.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"300583","symbol_name":"赛托生物","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1405158.html","article_id":"2611132885","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2611132885","pubTimestamp":1770971789,"columns":[],"sourceInfo":{"source_id":"highlight_zhitongcaijin","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，赛托生物 发布公告，公司控股子公司山东斯瑞药业有限公司近日收到欧洲药品质量管理局签发的原料药欧洲药典适用性证书。涉及化学原料药名称：“BETAMETHASONE 倍他米松”。公司取得倍他米松原料药CEP证书，标志着公司该原料药可以在认可CEP 证书的国际市场进行销售，将为公司倍他米松原料药拓展国际市场带来积极的影响，进一步丰富公司的产品线，有利于提升公司在化学原料药领域的市场竞争力。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"300583":"赛托生物","BK0239":"医药制造"},"translate_title":"Saito Biotech (300583. SZ) obtained the CEP certificate for betamethasone API","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300583":1.5},"content_text":"智通财经APP讯，赛托生物(300583.SZ)发布公告，公司控股子公司山东斯瑞药业有限公司(以下简称“斯瑞药业”)近日收到欧洲药品质量管理局(以下简称“EDQM”)签发的原料药欧洲药典适用性证书(以下简称“CEP证书”)。涉及化学原料药名称：“BETAMETHASONE 倍他米松”。公司取得倍他米松原料药CEP证书，标志着公司该原料药可以在认可CEP 证书的国际市场进行销售，将为公司倍他米松原料药拓展国际市场带来积极的影响，进一步丰富公司的产品线，有利于提升公司在化学原料药领域的市场竞争力。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2611132885","isCrawlerRequest":true}